AstraZeneca (GB:AZN) has released an update.
AstraZeneca PLC has announced that as of 30 June 2024, their issued share capital with voting rights totals 1,550,268,075 ordinary shares, a critical figure for shareholders to determine their notification requirements under the UK’s transparency rules. The company, a leading biopharmaceutical entity specializing in prescription medicines for various diseases and conditions, operates globally and reaches patients in over 125 countries.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
